(Q51830796)
Statements
1 reference
Heterogeneous FDG-guided dose-escalation for locally advanced NSCLC (the NARLAL2 trial): Design and early dosimetric results of a randomized, multi-centre phase-III study. (English)
1 reference
1 reference
1 reference
1 reference
1 reference
Tine Bjørn Nielsen
1 reference
Christina Maria Lutz
1 reference
Mikkel Drøgemüller Lund
1 reference
Olfred Hansen
1 reference
Tine Schytte
1 reference
Marianne Marquard Knap
1 reference
Christa Haugaard Nyhus
1 reference
Wiviann Ottosson
1 reference
Patrik Sibolt
1 reference
Svetlana Borissova
1 reference
Gitte Persson
1 reference
5 July 2017
1 reference
124
1 reference
2
1 reference
311-317
1 reference
Identifiers
1 reference